Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 oct. 2025 08h18 HE | Source: Bleichmar Fonti & Auld

MLTX SECURITIES NOTICE: MoonLake Immunotherapeutics Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
08 oct. 2025 07h36 HE | Source: Bleichmar Fonti & Auld

MLTX INQUIRY NOTICE: MoonLake Immunotherapeutics Hit with Securities Fraud Investigation Due to Drug Trial Results -- Contact BFA Law

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
06 oct. 2025 14h35 HE | Source: Block & Leviton LLP

MoonLake Immunotherapeutics Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation

MoonLake Immunotherapeutics Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation.
29 sept. 2025 10h53 HE | Source: Block & Leviton LLP

BREAKING: MoonLake Immunotherapeutics Shares Down Over 85%; Investors Should Contact Block & Leviton to Potentially Recover Losses

Shares of MoonLake Immunotherapeutics are down over 85% today. Block & Leviton is investigating MoonLake's public statements about its drug trials.